Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -18.53% is 21% below its 5-year average of -15.34%, near the high end of its 5-year range (-338.53%–10.67%).
86.86% below its 12-month average of -9.92%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 10.67%.
OPERATING MARGIN
-18.53%
OPERATING MARGIN AVG TTM
-9.92%
OPERATING MARGIN AVG 3Y
-11.62%
OPERATING MARGIN AVG 5Y
-15.34%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-86.86%
CURRENT VS 3Y AVG
-59.45%
CURRENT VS 5Y AVG
-20.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
P3 Health Partners Inc.
Market Cap
$19.30M
Operating Margin
-18.53%
TTM Avg
-9.92%
3Y Avg
-11.62%
5Y Avg
-15.34%
Market Cap
$19.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$18.54M
Operating Margin
-835.53%
TTM Avg
-421.37%
3Y Avg
-210.69%
5Y Avg
-1650.61%
Market Cap
$17.71M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$17.50M
Operating Margin
-24.65%
TTM Avg
-26.95%
3Y Avg
-27.41%
5Y Avg
-18.80%
Market Cap
$17.27M
Operating Margin
-30712.68%
TTM Avg
-16099.03%
3Y Avg
-14791.19%
5Y Avg
-11673.89%
Market Cap
$21.40M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$16.78M
Operating Margin
-65.74%
TTM Avg
-32.87%
3Y Avg
-308.88%
5Y Avg
2329.03%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| P3 Health Partners Inc. (PIII) | $19.30M | -18.53% | -9.92% | -11.62% | -15.34% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.54M | -835.53% | -421.37% | -210.69% | -1650.61% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| NextCure, Inc. (NXTC)vs › | $20.32M | 0.00% | 0.00% | 0.00% | -30.70% |
| Cosmos Health Inc. (COSM)vs › | $17.50M | -24.65% | -26.95% | -27.41% | -18.80% |
| PAVmed Inc. (PAVM)vs › | $17.27M | -30712.68% | -16099.03% | -14791.19% | -11673.89% |
| Quantum BioPharma Ltd. (QNTM)vs › | $21.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Palatin Technologies, Inc. (PTN)vs › | $16.78M | -65.74% | -32.87% | -308.88% | 2329.03% |
| Lipocine Inc. (LPCN)vs › | $17.11M | -524.69% | -267.50% | -582.47% | -385.07% |
Gross Margin
-9.9%
Operating Margin
-18.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 10.67% |
| 2026-03-31 | 2.13% |
| 2025-12-31 | -39.98% |
| 2025-09-30 | -12.81% |
| 2025-06-30 | -9.59% |
| 2025-03-31 | -10.21% |
| 2024-12-31 | -35.19% |
| 2024-09-30 | -29.55% |
| 2024-06-30 | -8.26% |
| 2024-03-31 | -11.28% |
| 2023-12-31 | -18.53% |
| 2023-09-30 | -11.73% |
| 2023-06-30 | -6.39% |
| 2023-03-31 | -16.16% |
| 2022-12-31 | -207.79% |
| 2022-09-30 | -24.17% |
| 2022-06-30 | -338.53% |
| 2022-03-31 | -19.07% |
| 2021-12-31 | -65.23% |
| 2021-09-30 | -18.01% |
| 2021-06-30 | -17.96% |
| 2021-03-31 | -8.58% |
| 2020-12-31 | -3.28% |
| 2020-09-30 | -10.49% |
| 2020-06-30 | -3.99% |
| 2020-03-31 | -5.33% |
